Recombinant human PD-L1 protein, C-His (HEK293), expressed in HEK293 cell, and a purity of >95% as determined by Tris-Bis PAGE, >95% as determined by SEC-HPLC. It was purified by AC, and has a C-His tag. Due to glycosylation, the protein migrates to 35-42 kDa based on Tris-Bis PAGE result.
Molekulargewicht:
Due to glycosylation, the protein migrates to 35-42 kDa based on Tris-Bis PAGE result.
Reinheit:
>95% as determined by Tris-Bis PAGE, >95% as determined by SEC-HPLC
Sequenz:
19-238/290
Target-Kategorie:
Programmed cell death 1 ligand 1
Anwendungsbeschreibung:
Application Notes: Centrifuge tubes before opening. Reconstituting to a concentration more than 100 µg/ml is recommended. Dissolve the lyophilized protein in distilled water
Immobilized Human PD-L1, His Tag at 0.5 µg/ml (100 µl/Well). Dose response curve for Anti PD-L1 Ab, with the EC50 of 6.1 ng/ml determined by ELISA.
Immobilized Human PD-L1, His Tag at 0.5 µg/ml (100 µl/Well). Dose response curve for Anti-PD-L1 Ab. with the EC50 of 6.1/6.4/6.2 ng/ml determined by ELISA.
Immobilized Human PD-L1, His Tag at 0.5 µg/ml (100 µl/Well). Dose response curve for Anti-PD-L1 Ab. with the EC50 of 6.4/6.4/6.5/6.6 ng/ml determined by ELISA.
Recombinant PD-L1 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
The purity of PD-L1 is greater than 95% as determined by SEC-HPLC.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
